This teaching session provides an overview into the risks and prevalence of DKD in patients with T2 Diabetes, what the current standards of care are and how there has been a shift in the management in this t This teaching session provides an overview into the risks and prevalence of DKD in patients with T2 Diabetes, what the current standards of care are and how there has been a shift in the management in this treatment group.

• When, how and why to assess kidney function in people with T2DM
• New Developments in Diabetic Kidney Disease: What does the future hold?
• Guidelines          
• Implications for Primary Care

Speakers

Dr Smeeta Sinha
Consultant Nephrologist, Salford Royal Foundation Trust.
Clinical Lead for the North West NHS England Renal Network. 

Dr Amar Ali
GP Partner, Co-Investigator in the Diabetes Research Unit at East Lancashire Hospitals NHS Trust, CCG Diabetes Lead, GP with a special interest (GPwSI) in diabetes

Chairperson

Dr Jane Wilcock
GP, Clinical advisor RCGP, Chair overdiagnosis group RCGP, Vicechair NWE faculty RCGP

Awarded: 1 CPD Credit